At the time of writing, Amphastar Pharmaceuticals Inc [AMPH] stock is trading at $23.14, down -3.02%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMPH shares have lost -10.93% over the last week, with a monthly amount drifted -14.30%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on August 12, 2025, when Needham upgraded its rating to a Buy but kept the price target unchanged to $36 for it. Previously, JP Morgan downgraded its rating to Neutral on May 12, 2025, and kept the price target unchanged to $30. On February 04, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $36 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $55 on November 22, 2024. JP Morgan initiated its recommendation with a Overweight and recommended $60 as its price target on March 05, 2024. BofA Securities started tracking with a Neutral rating for this stock on November 17, 2023, and assigned it a price target of $63.
For the past year, the stock price of Amphastar Pharmaceuticals Inc fluctuated between $20.39 and $53.96. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $23.14 at the most recent close of the market. An investor can expect a potential return of 38.29% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
According to Amphastar Pharmaceuticals Inc [NASDAQ:AMPH], the company’s sales were 722.68M for trailing twelve months, which represents an -4.38% plunge. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.18 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] has a current ratio of 3.29. Also, the Quick Ratio is 2.21, while the Cash Ratio stands at 1.06. Considering the valuation of this stock, the price to sales ratio is 1.49, the price to book ratio is 1.42 and price to earnings (TTM) ratio is 8.66.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on Oct 01 ’25 when 500.0 shares were sold. Director, Petersen Floyd F. completed a deal on Oct 01 ’25 to buy 500.0 shares. Meanwhile, Director Petersen Floyd F. sold 500.0 shares on Sep 02 ’25.
